CLINICAL TRIALS PROFILE FOR LUMIFY PRESERVATIVE FREE
✉ Email this page to a colleague
All Clinical Trials for LUMIFY PRESERVATIVE FREE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT05360784 ↗ | A Multi-Center, Double-Masked, Randomized, Active-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution 0.025% Preservative-Free Formulation With Lumify® 0.025% in Adult Subjects With Ocular | Not yet recruiting | Bausch & Lomb Incorporated | Phase 3 | 2022-05-01 | This is a multi-center, double-masked, randomized, active-controlled, parallel-group, efficacy and safety study that will enroll 386 participants at up to six clinical sites. Participants with ocular redness will be randomized to receive either brimonidine tartrate ophthalmic solution 0.025%, preservative-free formulation, or Lumify® (brimonidine tartrate ophthalmic solution 0.025%). Participants will be treated with study drug for approximately 4 weeks. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LUMIFY PRESERVATIVE FREE
Condition Name
Clinical Trial Locations for LUMIFY PRESERVATIVE FREE
Trials by Country
Clinical Trial Progress for LUMIFY PRESERVATIVE FREE
Clinical Trial Phase
Clinical Trial Sponsors for LUMIFY PRESERVATIVE FREE
Sponsor Name
